Drug-activation of brain reward pathways.
Wise
R A
RA
Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD 21224, USA.
D000818:Animals; D016739:Behavior, Addictive / Q000503:physiopathology*; D001921:Brain / Q000187:drug effects*; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology; D006213:Hallucinogens / Q000494:pharmacology; D006801:Humans; D007033:Hypothalamus, Middle / Q000187:drug effects; D013287:Illicit Drugs / Q000494:pharmacology*; D008959:Models, Neurological; D009294:Narcotics / Q000494:pharmacology; D009434:Neural Pathways / Q000187:drug effects; D018722:Nicotinic Agonists / Q000494:pharmacology; D009714:Nucleus Accumbens / Q000187:drug effects; D017397:Prefrontal Cortex / Q000187:drug effects; D051381:Rats; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D012201:Reward; D012653:Self Stimulation / Q000502:physiology; D019966:Substance-Related Disorders / Q000503:physiopathology*; D013681:Tegmentum Mesencephali / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000187:drug effects / Q000502:physiology
D000697:Central Nervous System Stimulants; D006213:Hallucinogens; D013287:Illicit Drugs; D009294:Narcotics; D018722:Nicotinic Agonists; D017981:Receptors, Neurotransmitter; D005680:gamma-Aminobutyric Acid; D004298:Dopamine